Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Dtsch Arztebl Int ; 110(18): 319-26, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23720698

RESUMO

BACKGROUND: The incidence of malignant mesothelioma in Germany is about 20 cases per million persons per year. Its association with asbestos exposure, usually occupational, has been unequivocally demonstrated. Even though the industrial use of asbestos was forbidden many years ago, new cases of mesothelioma continue to appear because of the long latency of the disease (median, 50 years). Its diagnosis and treatment still present a major challenge for ambulatory and in-hospital care and will do so for years to come. METHODS: This article is based on a selective review of the literature, along with data from the German Mesothelioma Register. RESULTS: 1397 people died of mesothelioma in Germany in 2010. A plateau in the incidence of the disease is predicted between 2015 and 2030. Most mesotheliomas arise from the pleura. The histological subtype and the Karnofsky score are the main prognostic factors. Only limited data are now available to guide treatment with a combination of the available methods (chemotherapy, surgery, radiotherapy). The prognosis is still poor, with a median survival time of only 12 months. Symptom control and the preservation of the patient's quality of life are the main aspects of care for patients with mesothelioma. CONCLUSION: The incidence of mesothelioma is not expected to drop in the next few years. The available treatments are chemotherapy, surgery, and radiotherapy. Specialized treatment centers now increasingly provide multimodal therapy for treatment of mesothelioma.


Assuntos
Asbestose/diagnóstico , Asbestose/terapia , Mesotelioma/diagnóstico , Mesotelioma/terapia , Exposição Ocupacional/estatística & dados numéricos , Derrame Pleural Maligno/diagnóstico , Derrame Pleural Maligno/terapia , Asbestose/mortalidade , Causalidade , Comorbidade , Medicina Baseada em Evidências , Humanos , Mesotelioma/mortalidade , Saúde Ocupacional/estatística & dados numéricos , Derrame Pleural Maligno/mortalidade , Prevalência , Prognóstico , Medição de Risco , Fatores de Risco , Análise de Sobrevida , Taxa de Sobrevida , Resultado do Tratamento
3.
Innate Immun ; 18(2): 204-16, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21382908

RESUMO

Escherichia coli Nissle 1917 (EcN) bears a defect in its LPS biosynthesis leading to truncated variable oligosaccharide-antigen chains and a semi-rough phenotype. It is effectively inactivated by complement factors due to resolved serum resistance and is, therefore, safe as a probiotic strain, i.e. for the treatment of inflammatory gastrointestinal diseases. It is unknown whether the modification of LPS in EcN contributes to its probiotic properties. Purified LPS from EcN and wild-type LPS from uropathogenic E. coli W536 together with raw lysates of both strains were analyzed for their gene expression activity with human PBMCs measured by microarrays. Comparing the two LPS molecules and the two lysate variants with each other, respectively, no differences of transcriptional patterns were observed. However, when comparing LPS with lysate patterns, pro-inflammatory cytokine IL-12p40 was up-regulated by both LPS molecules and anti-inflammatory IL-10 by both lysates. The higher the lysate concentration, the higher IL-10 release from PBMCs, clearly exceeding LPS induced IL-12p40 release. Furthermore, inflammatory chemokine CCL24 (eotaxin) was down-regulated by lysates and quantitative real-time PCR revealed that EcN compared to wild-type LPS was 8 times stronger in down-regulation of CCL24. We conclude that truncated LPS may down-regulate CCL24-mediated inflammation and that EcN lysate contains as yet unidentified factors which preferably induce anti-inflammatory activity. Both effects may contribute to the probiotic properties of EcN.


Assuntos
Anti-Inflamatórios , Escherichia coli/fisiologia , Sistema Imunitário/efeitos dos fármacos , Monócitos/imunologia , Probióticos/farmacologia , Células Cultivadas , Quimiocina CCL24/fisiologia , DNA Complementar/biossíntese , DNA Complementar/genética , Endopeptidase K/metabolismo , Ensaio de Imunoadsorção Enzimática , Escherichia coli/crescimento & desenvolvimento , Expressão Gênica/efeitos dos fármacos , Humanos , Imunocompetência/efeitos dos fármacos , Hibridização in Situ Fluorescente , Interleucina-10/biossíntese , Interleucina-12/biossíntese , Lipopolissacarídeos/farmacologia , Análise em Microsséries , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Reação em Cadeia da Polimerase em Tempo Real
4.
Recent Results Cancer Res ; 189: 79-95, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21479897

RESUMO

The strong relationship between mesothelioma and asbestos exposure is well established. The analysis of lung asbestos burden by light and electron microscopy assisted to understand the increased incidence of mesothelioma in asbestos mining and consuming nations.The data on the occupational exposure to asbestos are important information for the purpose of compensation of occupational disease No. 4105 (asbestos-associated mesothelioma) in Germany.However, in many cases the patients have forgotten conditions of asbestos exposure or had no knowledge about the used materials with components of asbestos. Mineral fiber analysis can provide valuable information for the research of asbestos-associated diseases and for the assessment of exposure. Because of the variability of asbestos exposure and long latency periods, the analysis of asbestos lung content is a relevant method for identification of asbestos-associated diseases. Also, sources of secondary exposure, so called "bystander exposition" or environmental exposure can be examined by mineral fiber analysis.Household contacts to asbestos are known for ten patients (1987-2009) in the German mesothelioma register; these patients lived together with family members working in the asbestos manufacturing industry.Analysis of lung tissue for asbestos burden offers information on the past exposure. The predominant fiber-type identified by electron microscopy in patients with mesothelioma is amphibole asbestos (crocidolite or amosite). Latency times (mean 42.5 years) and mean age at the time of diagnose in patients with mesothelioma are increasing (65.5 years). The decrease of median asbestos burden of the lung in mesothelioma patients results in disease manifestation at a higher age.Lung dust analyses are a relevant method for the determination of causation in mesothelioma. Analysis of asbestos burden of the lung and of fiber type provides insights into the pathogenesis of malignant mesothelioma. The most important causal factor for the development of mesothelioma is still asbestos exposure.


Assuntos
Amianto/análise , Mesotelioma/patologia , Fibras Minerais/análise , Exposição Ocupacional , Neoplasias Pleurais/induzido quimicamente , Neoplasias Pleurais/patologia , Idoso , Amianto/toxicidade , Amianto Amosita/análise , Amiantos Anfibólicos/análise , Amiantos Anfibólicos/toxicidade , Asbesto Crocidolita/análise , Asbestos Serpentinas/análise , Asbestos Serpentinas/toxicidade , Feminino , Alemanha , Humanos , Neoplasias Pulmonares/induzido quimicamente , Neoplasias Pulmonares/diagnóstico , Masculino , Mesotelioma/induzido quimicamente , Microscopia Eletrônica , Pessoa de Meia-Idade , Fibras Minerais/toxicidade , Doenças Profissionais
5.
Med Klin (Munich) ; 104(10): 765-71, 2009 Oct 15.
Artigo em Alemão | MEDLINE | ID: mdl-19856150

RESUMO

Malignant peritoneal mesotheliomas arise mainly in male patients and the median age of initial diagnosis is about 56 years. Epitheloid subtype predominates in peritoneal mesotheliomas. Asbestos exposure is the best-known and most common risk factor associated with the development of both pleural and peritoneal mesotheliomas and, therefore, about 90% of cases can be assessed as asbestos-associated. Patients with peritoneal mesotheliomas have distinctly higher asbestos burden of the lungs than patients with pleural mesotheliomas. The mean latency period between exposure and diagnosis of peritoneal mesothelioma ranges from 35 to 40 years and is comparable to that of pleural mesothelioma. Mesothelioma of the tunica vaginalis testis also belongs to the group of peritoneal mesotheliomas. No significant evidence exists for the classification of well-differentiated papillary mesothelioma, solitary fibrous tumor, adenomatoid tumor, primary peritoneal serous borderline tumor, and benign multicystic mesothelioma as asbestos-associated tumors. Except malignant mesotheliomas, the induction of other abdominal tumors is independent of an exposure to asbestos dust.


Assuntos
Asbestose/epidemiologia , Mesotelioma/epidemiologia , Programas Nacionais de Saúde/estatística & dados numéricos , Neoplasias Peritoneais/epidemiologia , Asbestose/classificação , Asbestose/diagnóstico , Asbestose/patologia , Biópsia , Causalidade , Estudos Transversais , Feminino , Alemanha , Humanos , Seguro de Acidentes/legislação & jurisprudência , Seguro de Acidentes/estatística & dados numéricos , Masculino , Mesotelioma/classificação , Mesotelioma/etiologia , Mesotelioma/patologia , Pessoa de Meia-Idade , Programas Nacionais de Saúde/legislação & jurisprudência , Neoplasias Peritoneais/classificação , Neoplasias Peritoneais/etiologia , Neoplasias Peritoneais/patologia , Peritônio/patologia , Neoplasias Pleurais/classificação , Neoplasias Pleurais/epidemiologia , Neoplasias Pleurais/etiologia , Neoplasias Pleurais/patologia , Fatores de Risco , Indenização aos Trabalhadores/legislação & jurisprudência , Indenização aos Trabalhadores/estatística & dados numéricos
6.
Immunol Cell Biol ; 85(5): 383-90, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17404592

RESUMO

Plasmacytoid dendritic cells (PDC) in human blood are the main source of virus-induced interferon (IFN)-alpha. They exhibit a lineage-negative phenotype but all express BDCA-4, which is homologous to the neuronal receptor neuropilin-1. Specific staining with anti-BDCA-4 antibody is used for positive isolation of PDC from blood by magnetic cells sorting. Here, it is demonstrated that these positively selected PDC showed reduced or completely abolished IFN-alpha release compared to unstained PDC, which were negatively selected by magnetic depletion of lineage-positive blood mononuclear cells. In addition, treatment of these unstained PDC with anti-BDCA-4 mAb also resulted in at least two-fold lower or reduced virus-induced IFN-alpha production. It is shown that the antibody not only affects cell survival or block virus attachment but also reduces IFN-alpha release induced by non-viral CpG oligodeoxynucleotides. In conclusion, data suggest an immunoregulatory role for BDCA-4 on PDC as demonstrated for IFN-alpha response to virus.


Assuntos
Anticorpos Monoclonais/farmacologia , Células Dendríticas/imunologia , Células Dendríticas/virologia , Interferon gama/biossíntese , Neuropilina-1/imunologia , Vírus do Sarcoma de Rous/efeitos dos fármacos , Vírus do Sarcoma de Rous/fisiologia , Separação Celular , Células Dendríticas/efeitos dos fármacos , Citometria de Fluxo , Humanos , Interferon gama/genética , Fenótipo , Transcrição Gênica/efeitos dos fármacos , Ligação Viral/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...